Core Insights - Bayer is participating in the 8th China International Import Expo (CIIE) with a focus on its mission of "sharing health and eliminating hunger," showcasing its commitment to the Chinese market and its confidence in leveraging local development opportunities [1][2] Group 1: Participation and Commitment - Bayer will have a total exhibition area of 800 square meters across two halls, continuing its presence at the CIIE for the eighth consecutive year, highlighting its long-term commitment to the Chinese market [1] - The company aims to leverage the CIIE as a strategic platform to connect with global innovations and observe China's market opportunities [2] Group 2: Product Innovations - Bayer will showcase approximately 26 highlight exhibits, including 5 global debuts, 8 China debuts, and 13 CIIE debuts, emphasizing its century-long innovation legacy [2] - In the prescription drug sector, Bayer will present innovations in oncology, cardiovascular, ophthalmology, and women's health, including the domestic debut of Eylea® 8mg, which offers significant benefits for patients with age-related macular degeneration [3] - The imaging diagnostics segment will feature locally produced products, including the MEDRAD® Stellant D-CE high-pressure injection system, marking a key milestone in local production [4] - In the consumer health sector, Bayer will introduce new products addressing allergies, digestive health, nutrition, and skin care, including the new member of the Claritin® family, which is recommended for children [5] Group 3: Agricultural Innovations - Bayer will integrate global wisdom with local innovation in agriculture, presenting 7 China debuts and 8 CIIE debuts, including new products in crop health and seed varieties tailored to local farmer needs [6] - The company is committed to sustainable agricultural development in China, showcasing its third regenerative agriculture demonstration farm and various local partnerships aimed at enhancing productivity for smallholder farmers [10] Group 4: Collaborative Efforts - Bayer emphasizes the importance of local collaboration for effective innovation, having established partnerships with startups and academic institutions to drive advancements in healthcare and agricultural technology [7][9] - The company is launching the Bayer Health Consumer Innovation Cooperation Center (CCIP) in 2024 to foster a collaborative ecosystem among top universities and research institutions in China [9] Group 5: Future Outlook - Bayer's participation in the CIIE is seen as a significant opportunity to align with China's development trajectory, aiming to create a better life for the Chinese populace through innovation and collaboration [10]

"重回少女肌""早抗衰老，晚调代谢"……近期，一款ZUCCARI意卡莉"双抗桦树饮"在各大电商平台蹿火，号称意大利原装进口，暗示有抗炎的功效，同时 打出"伊能静同款""胡兵同款"醒目宣传语。在官方旗舰店，"双抗桦树饮"卖到300元/瓶。功效下的高价格，引发消费者对其是否是智商税的质疑。 意卡莉在国内的操盘主体为A股上市公司青木科技，意卡莉是其近年来孵化得比较成功的品牌之一，去年为其业绩增长提供帮助。财报显示，去年青木科技 品牌孵化与管理业务的毛利率接近80%，远超其他业务。 明星网红推荐 "桦树饮可以给我的皮肤提供足够的水分，我建议你们都吃一条"……打开意卡莉官方账号，明星推荐视频让人眼花缭乱。 今年3月，意卡莉宣布胡兵担任意卡莉桦树饮全球时尚代言人，胡兵在社交平台视频和直播中多次介绍该产品。5月6日，伊能静社交账号发布视频，到意卡 莉位于意大利的工厂溯源，并与意卡莉全球业务总监LORENZO进行交流。不仅如此，香港师姐、李多海、安吉小朋友、两只小狗六等网络达人也在推 荐"双抗桦树饮"。 一时间，意卡莉的名字充斥在各大社交和电商平台。蝉妈妈数据显示，意卡莉带货的直播间近40个。 "双抗桦树饮"其实是一款口服液 ...